Magri, M D

Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee. [electronic resource] - Tumori Feb 1991 - 49-51 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0300-8916

10.1177/030089169107700112 doi


Aged
Drug Evaluation
Epirubicin--therapeutic use
Female
Humans
Lung Neoplasms--drug therapy
Male
Mesothelioma--drug therapy
Middle Aged